Zhejiang Shapuaisi Pharmaceutical ,Ltd.'s receivables is $48M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Zhejiang Shapuaisi Pharmaceutical ,Ltd. (603168.SS) currently reports a receivables of $48M as of September 2026. That compares with $62M in the prior-year period — down 21.6% year over year. Use the charts on this page to explore Zhejiang Shapuaisi Pharmaceutical ,Ltd.'s receivables history and peer comparisons.
Zhejiang Shapuaisi Pharmaceutical ,Ltd.'s receivables decreased from $62M to $48M — a 21.6% year-over-year decrease (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Zhejiang Shapuaisi Pharmaceutical ,Ltd. reported $48M in receivables as of September 2026. That compares with $62M in the prior-year period — down 21.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current receivables of $48M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Zhejiang Shapuaisi Pharmaceutical ,Ltd., and consider following 603168.SS for alerts when major investors trade the stock.